Table 3.

Laboratory data before and after the treatment of thalidomide

Inflammatory markers (median [interquartile range])	3 months before	Baseline	3 months	6 months	9 months	12 months
CRP (mg/L)	9.0 (5.0, 15.0)	16.50 (3.75, 27.75)	5.50 (3.25, 21.23)	5.0 (1.0, 13.0)	6.0 (2.50,28.0)	1.0 (1.0,14.50)
ESR (mm/h)	14.0 (8.0, 30.0)	24.0 (8.0, 36.0)	9.50 (5.75, 16.0)	8.0 (4.0, 19.0)	8.0 (5.0,19.0)	7.0 (2.75,15.8)

CRP and ESR values were recorded at baseline, 3 months before thalidomide and at 3, 6, 9, and 12 months on thalidomide. Data are median (interquartile range)